Inceptor Bio is committed to confronting one of humanity’s single most complex problems — difficult-to-cure cancers. Every day, we are working to enable patients with these cancers to realize what was once an impossible dream — to be cured.
Led by scientific and industry pioneers, Inceptor Bio is pioneering next-generation cell therapies to cure difficult to treat cancers.
We are strategically advancing a pipeline of diversified cell therapies for oncology, including CAR-T, CAR-M, and CAR-NK products engineered for optimal efficacy against solid tumors.
Inceptor Bio has built a team that has deep industry expertise. What draws this team together is a shared passion to realize the tremendous potential of cell and gene therapies to deliver cures for cancer patients.
A key pillar of Inceptor Bio’s strategy is alleviating what has been a major bottleneck for cell therapies – access to early-phase manufacturing. We have established our Advanced Manufacturing Platform (AMP+), based in Gainesville, Florida.